Figure 1. Metastatic ability of SCLC.

Schematic representation of common metastatic sites in SCLC patients (A), genetically engineered mouse models (B), and pre‐clinical human models in mice (C). CDX, circulating tumor cell‐derived xenograft. See text for details.